P2.13-43 Phase 1 Study of the Anti-Her3 Antibody Drug Conjugate U3-1402 in Metastatic or Unresectable EGFR-Mutant NSCLC
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1438
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV